These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28585279)

  • 21. Circulating bile acid concentrations and non-alcoholic fatty liver disease in Guatemala.
    Rivera-Andrade A; Petrick JL; Alvarez CS; Graubard BI; Florio AA; Kroker-Lobos MF; Parisi D; Freedman ND; Lazo M; Guallar E; Groopman JD; Ramirez-Zea M; McGlynn KA
    Aliment Pharmacol Ther; 2022 Jul; 56(2):321-329. PubMed ID: 35484638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of bile acid spectrum in the evaluation of hepatic injury in children with infectious mononucleosis caused by Epstein Barr virus infection.
    Shen R; Zhou Y; Zhang L; Yang S
    Front Pediatr; 2023; 11():1109762. PubMed ID: 37025296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating bile acids in healthy adults respond differently to a dietary pattern characterized by whole grains, legumes and fruits and vegetables compared to a diet high in refined grains and added sugars: A randomized, controlled, crossover feeding study.
    Ginos BNR; Navarro SL; Schwarz Y; Gu H; Wang D; Randolph TW; Shojaie A; Hullar MAJ; Lampe PD; Kratz M; Neuhouser ML; Raftery D; Lampe JW
    Metabolism; 2018 Jun; 83():197-204. PubMed ID: 29458053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: role of glycine conjugates.
    Chatterjee S; Bijsmans IT; van Mil SW; Augustijns P; Annaert P
    Toxicol In Vitro; 2014 Mar; 28(2):218-30. PubMed ID: 24211540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
    Friedrich D; Marschall HU; Lammert F
    BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis.
    Hua MC; Su HM; Yao TC; Kuo ML; Lai MW; Tsai MH; Huang JL
    PLoS One; 2017; 12(7):e0182277. PubMed ID: 28759573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated with Specific Changes in Circulating Bile Acids.
    Gottlieb A; Bechmann L; Canbay A
    Ann Hepatol; 2018; 17(3):340-341. PubMed ID: 29735794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults.
    Chen YM; Liu Y; Zhou RF; Chen XL; Wang C; Tan XY; Wang LJ; Zheng RD; Zhang HW; Ling WH; Zhu HL
    Sci Rep; 2016 Jan; 6():19076. PubMed ID: 26743949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids.
    Yang T; Shu T; Liu G; Mei H; Zhu X; Huang X; Zhang L; Jiang Z
    J Steroid Biochem Mol Biol; 2017 Sep; 172():69-78. PubMed ID: 28583875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.
    Bechmann LP; Kocabayoglu P; Sowa JP; Sydor S; Best J; Schlattjan M; Beilfuss A; Schmitt J; Hannivoort RA; Kilicarslan A; Rust C; Berr F; Tschopp O; Gerken G; Friedman SL; Geier A; Canbay A
    Hepatology; 2013 Apr; 57(4):1394-406. PubMed ID: 23299969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients.
    López-Bautista F; Barbero-Becerra VJ; Ríos MY; Ramírez-Cisneros MÁ; Sánchez-Pérez CA; Ramos-Ostos MH; Uribe M; Chávez-Tapia NC; Juárez-Hernández E
    Ann Hepatol; 2020; 19(5):482-488. PubMed ID: 32717363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship between normal serum uric acid levels and nonalcoholic fatty liver disease in postmenopausal women].
    Liu P; Ma F; Lou H; Zhu Y; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):53-7. PubMed ID: 24721245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease.
    Sayın O; Tokgöz Y; Arslan N
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced lysosomal acid lipase activity - A potential role in the pathogenesis of non alcoholic fatty liver disease in pediatric patients.
    Selvakumar PK; Kabbany MN; Lopez R; Tozzi G; Alisi A; Alkhouri N; Nobili V
    Dig Liver Dis; 2016 Aug; 48(8):909-13. PubMed ID: 27198736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of conjugated and unconjugated bile acid transport via human organic solute transporter α/β.
    Suga T; Yamaguchi H; Ogura J; Mano N
    Biochim Biophys Acta Biomembr; 2019 May; 1861(5):1023-1029. PubMed ID: 30853579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
    Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
    Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary fat composition shapes bile acid metabolism and severity of liver injury in a pig model of pediatric NAFLD.
    Manjarín R; Dillard K; Coffin M; Hernandez GV; Smith VA; Noland-Lidell T; Gehani TR; Smart HJ; Wheeler K; Sprayberry KA; Edwards MS; Fanter RK; Glanz H; Immoos C; Santiago-Rodriguez TM; Blank JM; Burrin DG; Piccolo BD; Abo-Ismail M; La Frano MR; Maj M
    Am J Physiol Endocrinol Metab; 2022 Sep; 323(3):E187-E206. PubMed ID: 35858244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease.
    Lake AD; Novak P; Shipkova P; Aranibar N; Robertson D; Reily MD; Lu Z; Lehman-McKeeman LD; Cherrington NJ
    Toxicol Appl Pharmacol; 2013 Apr; 268(2):132-40. PubMed ID: 23391614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A possible role of chenodeoxycholic acid and glycine-conjugated bile acids in fibrotic steatohepatitis in a dietary rat model.
    Jia X; Suzuki Y; Naito H; Yetti H; Kitamori K; Hayashi Y; Kaneko R; Nomura M; Yamori Y; Zaitsu K; Kato M; Ishii A; Nakajima T
    Dig Dis Sci; 2014 Jul; 59(7):1490-501. PubMed ID: 24448653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease.
    Papandreou D; Karabouta Z; Pantoleon A; Rousso I
    Appetite; 2012 Dec; 59(3):939-44. PubMed ID: 23000278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.